Double-blind placebo-controlled randomized efficacy and safety trial of add-on treatment of dimebon plus risperidone in schizophrenic patients during transition from acute psychotic episode to remission.

1/2/13

Luna Litami (10711146) Angga Faletra (10711228) Sofi Aryani SR

Click to edit Master subtitle style

1/2/13

Judul dan abstrak

1/2/13

Introduksi

1/2/13

Bahan dan Cara

1/2/13

Subyek penelitian Hal. 160

1/2/13

1/2/13

Hasil

1/2/13

Diskusi

1/2/13

1/2/13